期刊文献+

γ射线照射单倍型供者淋巴细胞输注抗白血病作用的实验研究 被引量:7

Study of graft versus leukemia activity of γ ray irradiated haplomismatched donor lymphocytes infusion
原文传递
导出
摘要 目的 探讨 7.5Gyγ射线照射单倍型供者淋巴细胞输注 (DLI)的体内抗白血病作用。方法 荷L61 5白血病 61 5(H 2 k) /BALB/c(H 2 d)F1小鼠 ,于接种L61 5白血病细胞后第 3天接受环磷酰胺(CTX ,2 0 0mg/kg)化疗 ,分别于化疗后第 3 ,5,7天输注 1× 1 0 7经 7.5Gyγ射线照射的亲代BALB/c(H 2 d)小鼠脾淋巴细胞 ,观察抗白血病作用。结果 单倍型供鼠脾淋巴细胞体外经 7.5Gyγ射线照射后 ,增殖能力趋于消失 ,而细胞毒活性增强。输注给荷瘤L61 5CF1小鼠后 ,受鼠的生存期延长为 (1 5.4± 1 .2 )d ,与CTX化疗对照组比较 ,差异具有显著的统计学意义 (t=1 0 .0 3 ,P <0 .0 0 1 ) ,且无严重移植物抗宿主病 (GVHD)发生。结论  7.5Gyγ射线照射单倍型供者淋巴细胞输注能够在减轻GVHD发生的同时 ,保留抗白血病作用 ,为延迟或预防白血病复发提供一种简便易行的方法。 Objective To explore graft versus leukemia activity of 7.5?Gy γ ray irradiated haplomismatched donor lymphocytes infusion(DLI). Methods L615 cells loaded 615(H2 k)/BALB/c(H 2 d)F 1 mice were infused with irradiated haplo mismatched donor lymphocytes at 3,5,7 days after CTX(200?mg/kg) treatment which was given at the 3rd day after L615 cells inoculation. Results T cells irradiated with 7.5?Gy γ ray lost their proliferative capacity but preserved their cytotoxic activity against allogeneic targets.Survival of these recipient mice was longer than that of control(t=10.03,P<0.001) with no severe graft versus host disease(GVHD). Conclusion 7.5?Gy γ irradiation attenuated the GVHD inducing potential of allogeneic lymphocytes while preserving their graft versus leukemia activity.It provides a simple modality to postpone and prevent leukemia relapse.
出处 《中华血液学杂志》 CAS CSCD 北大核心 2000年第2期81-83,共3页 Chinese Journal of Hematology
基金 广东省医学科学技术重点基金
关键词 放射免疫疗法 淋巴细胞输注 白血病 Radioimmunotherapy Lymphocyte transfusion Leukemia
  • 相关文献

参考文献2

二级参考文献8

共引文献130

同被引文献50

  • 1陈字,丁天凌,陈勤奋,叶静,陈波斌,谢彦晖,谢毅.非清髓性异基因骨髓移植小鼠模型的建立[J].上海实验动物科学,2004,24(2):81-84. 被引量:2
  • 2仲任,罗斌,胡俊斌,宋善俊.半相合供者淋巴细胞输注抗急性非淋巴细胞性白血病的实验研究[J].临床血液学杂志,2004,17(5):277-279. 被引量:8
  • 3李高峰,曹建国,庄英帜.甲基莲心碱增强环磷酰胺诱导小鼠Lewis肺癌细胞凋亡的作用[J].实用癌症杂志,2005,20(2):135-137. 被引量:3
  • 4Kolb HJ, Mittermuller J, Clemm C, et al. Donor leukocyte transfusions for treatment of recurrent chronic myeloid leukemia in marrow transplant patients. Blood,1990, 76: 2462-2465.
  • 5Collins RHJ, Goldstein S, Giralt S, et al. Donor leukocyte infusions in acute lymphocytic leukemia. Bone Marrow Transplant, 2000, 26:511.
  • 6Rowe JM. Graft-versus-disease effect following allogeneic transplantation for acute leukemia. Best Pract Res Clin Haematol, 2008, 21: 485-502.
  • 7Igietseme JU, Smith K, Simmons A, et al. Effect of gamma-irradiation on the effector function of T lymphocytes in microbial control. Int J Radiat Biol, 1995, 67: 557.
  • 8Soiffer RJ. Donor lymphocyte infusion for acute myeloid leukemia. Best Pract Res Clin Haematol, 2008, 21: 455-456.
  • 9Ruggeri L,Capanni M,Urbani E,et al.Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants[J].Science,2002,295(5562):2097-2100.
  • 10Lokhorst H M,Schattenberg A,Cornelissen J J,et al.Donor leukocyte infusions are effective in relapsed multiple myeloma after allogeneic bone marrow transportation[J].Blood,1997,90(10):4206-4211.

引证文献7

二级引证文献18

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部